Canaccord Slightly Lowers SSR Mining’s Price Target Off Back Of 2022 Guidance

Recently, SSR Mining Inc. (TSX: SSRM) announced full-year 2021 production results, a three-year outlook, and a 40% increase to the current dividend. First, the company produced 794,456 gold equivalent ounces for the full year, almost beating their high-end 800,000-ounce guidance. The company had all-in sustaining costs of $982 per ounce, below their $1,000 low-end estimate.

For the 2022 guidance, the company expects gold production to come in at 585,000 to 655,000 ounces and 8,000,000 to 9,000,000 million ounces of silver. This would bring the total gold equivalent ounces produced to between 700,000 and 780,000 ounces, with a cash cost of $790 to $850 per ounce and an all-in sustaining cost of $1,120 to $1,180 per ounce. The company also expects to spend a total of $76 million, with $22 million earmarked for growth CAPEX and the other $54 million for exploration and development.

You can see SSR’s three-year production outlook below.

SSR Mining currently has 4 analysts covering the stock with an average 12-month price target of US$25.44, or a 52% upside to the current stock price. All four analysts have buy ratings on the stock. The street high sits at US$29.75, or a 78% upside, while the lowest price target comes in at US$21.

Canaccord Genuity lowered their 12-month price target from C$28 to C$27 and reiterated their buy rating, saying that this puts a solid ending to 2021. They say that the production results came in mixed, with gold production being roughly 9% higher than estimates while silver came in 4% lower than estimates.

Gold production by mine, Marigold was the only mine to not beat Canaccord estimates, only by 1%, while Seabee beat their estimates by 40% and Copler by 7%. The companies all-in sustaining costs came in lower than Canaccord expected, though they believe this is only being deferred into 2022.

Commenting on 2022 guidance, Canaccord stated that it “appears modestly weaker than our estimates.” With Copler and Marigold being 9% and 8% below Canaccord’s estimates. The big miss was in the CAPEX, the average CAPEX spend on each mine is 42% below what Canaccord expected. Additionally, the companies all-in sustaining costs are roughly 19% higher than Canaccord previously estimated.

Lastly, Canaccord says that the increased dividend brings the companies yield to roughly 1.7%. In 2021, the company returned roughly $200 million to shareholders which put the yield to 5%.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Hidden Environmental Cost of Fertilizer | Robin Dow

Could Silver Stay This High? | Joaquín Marias – Argenta Silver

Can Historic Silver Data Turn Into a New Mine? | Rob Macdonald – Equity Metals

Recommended

First Majestic Drills 3.43 g/t Gold Over 24.4 Metres At Jerritt Canyon

Goliath Resources Secures 100% Ownership of Golddigger Property in BC’s Golden Triangle

Related News

Curaleaf: Canaccord Raises Price Target To $23.50

Wednesday, Canaccord came out with their updated valuations for the large three multi-state operators. In...

Saturday, January 16, 2021, 01:43:00 PM

Green Thumb: Haywood Lowers Price Target On Slower Growth Expectations

Green Thumb Industries Inc. (CSE: GTII) announced that they will be reporting their third-quarter financial...

Thursday, October 28, 2021, 05:33:00 PM

Endeavour Silver Beats BMO’s Production Estimates By 30%

Last week, Endeavour Silver Corp. (TSX: EDR) announced their third quarter production highlights. For the...

Thursday, October 14, 2021, 03:20:00 PM

Raymond James Calls Indiva 75% Undervalued, Gives 243% Upside Target

This week, Raymond James initiated coverage on Indiva Limited (TSXV: NDVA) with a $1.75 price...

Thursday, September 9, 2021, 03:42:00 PM

Well Health: Canaccord Reiterates Ratings Following Recent Acquisition

Last week WELL Health Technologies (TSX: WELL) announced their latest acquisition, a majority stake in...

Friday, September 10, 2021, 03:29:00 PM